Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Melatonin by RepoCeuticals for Radiodermatitis: Likelihood of Approval
Melatonin is under clinical development by RepoCeuticals and currently in Phase II for Radiodermatitis. According to GlobalData, Phase II drugs...
Data Insights
Melatonin by RepoCeuticals for Anorectal Disease: Likelihood of Approval
Melatonin is under clinical development by RepoCeuticals and currently in Phase II for Anorectal Disease. According to GlobalData, Phase II...